PODCAST: PSA testing in general practice - screening, assessment and monitoring
About the Podcast
Prostate cancer is the most diagnosed cancer and the second most common cause of cancer-related deaths in Australian males. Therefore, the screening, assessment, diagnosis and treatment of this disease is vital for general practitioners.
However, there has always been conflicting advice on whether a GP should order PSA (prostate specific antigen) testing for their patients, due to the ambiguity around the potential benefits and risks of the test. Since the existing guidelines were released in 2015, there have been significant advancements in technologies available to diagnose and monitor prostate cancer with better outcomes for patients.
Key Points Addressed in this Podcast
-
PSA testing best-practice
-
Harm minimisation to reduce over-diagnosis and treatment
-
Why active surveillance is safe and appropriate for low grade cancers
-
How to support patients who are anxious on active surveillance
Free On-Demand Webinar
Join us in this webinar as we discuss the advancements in screening and assessment that can inform contemporary care in primary health settings. View the webinar here: Prostate health: advances in screening and assessment
Additional Practitioner Resources
For health professionals: The evolution of PSA testing | Healthy Male
Blog News — A/Prof Jeremy Grummet – Melbourne Urological Surgeon
Modern paradigms for prostate cancer detection and management | The Medical Journal of Australia
Additional Patient Resources
Prostate Cancer Specialist Telenursing Service | PCFA Ph: 1800 22 00 99
Prostate Cancer Specialist Nursing Service | PCFA
Podcast Partner
This podcast is bought to you by Healthy Male. Additional learning resources including webinars, online learning modules and blogs can be viewed here.
Assoc Prof Jeremy Grummet is a urological surgeon with specific training and expertise in urological cancers. He is a pioneer of focal therapy for intermediate-risk localised prostate cancer, having started practising focal therapy in 2015 and is co-principal investigator on the LIBERATE focal brachytherapy clinical registry.
He also performs MRI-targeted transperineal biopsy for maximal accuracy and minimal risk in prostate cancer diagnosis. As a strong advocate of active surveillance for low-risk prostate cancer to minimise unnecessary treatment, Jeremy was a site investigator at Alfred Health on the PRIAS study, the largest worldwide study assessing outcomes for patients on active surveillance. Jeremy is an expert advisor for Healthy Male.
Become a member and get unlimited access to 100s of hours of premium education.
Learn more
Stories about topical steroid withdrawal are difficult to put into context for both consumers and health professionals. The outcome is that many consumers are avoiding using topical corticosteroids, which in many cases, makes it harder to manage conditions such as eczema.
You are working in ED and have received a call from Pathology regarding blood results that you took earlier on Lauren, who is 18 years old and 30 weeks pregnant with her first child. Discover the diagnosis behind Lauren's abnormal blood results and learn the symptoms, risks, and management of this life-threatening obstetric emergency.
Jaime has suffered from severe eczema for most of his life. This podcast delves into the interactions that take place between consumers and health professionals in the eczema journey.